Vanguard Group Inc. increased its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 5.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,360,246 shares of the construction company's stock after purchasing an additional 226,251 shares during the quarter. Vanguard Group Inc. owned 5.31% of Aspen Aerogels worth $51,800,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Telemark Asset Management LLC lifted its stake in Aspen Aerogels by 26.8% in the 4th quarter. Telemark Asset Management LLC now owns 1,892,424 shares of the construction company's stock worth $22,482,000 after purchasing an additional 400,000 shares in the last quarter. State Street Corp increased its position in shares of Aspen Aerogels by 0.6% during the third quarter. State Street Corp now owns 1,410,543 shares of the construction company's stock valued at $39,058,000 after acquiring an additional 8,344 shares during the last quarter. Geode Capital Management LLC raised its position in Aspen Aerogels by 5.7% in the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company's stock valued at $38,385,000 after purchasing an additional 75,024 shares during the period. Rice Hall James & Associates LLC boosted its position in shares of Aspen Aerogels by 3.6% during the fourth quarter. Rice Hall James & Associates LLC now owns 554,202 shares of the construction company's stock worth $6,584,000 after buying an additional 19,089 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Aspen Aerogels by 7.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 549,709 shares of the construction company's stock worth $6,531,000 after buying an additional 40,279 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.
Aspen Aerogels Stock Down 2.4 %
Shares of Aspen Aerogels stock traded down $0.13 during trading on Tuesday, hitting $5.19. 1,605,950 shares of the stock were exchanged, compared to its average volume of 1,895,706. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The firm's 50-day moving average price is $7.47 and its 200 day moving average price is $12.84. The stock has a market cap of $425.71 million, a price-to-earnings ratio of 32.41 and a beta of 2.35. Aspen Aerogels, Inc. has a 12-month low of $4.80 and a 12-month high of $33.15.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on ASPN shares. Barclays decreased their target price on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. Canaccord Genuity Group reduced their price target on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Seaport Res Ptn cut shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Finally, B. Riley dropped their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research note on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Aspen Aerogels currently has a consensus rating of "Moderate Buy" and an average price target of $19.11.
View Our Latest Stock Report on ASPN
Aspen Aerogels Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.